Poseida Therapeutics Overview

  • Founded
  • 2014
Founded
  • Status
  • Public
  • Employees
  • 186
Employees
  • Stock Symbol
  • PSTX
Stock Symbol
  • Investments
  • 1
  • Share Price
  • $9.25
  • (As of Friday Closing)

Poseida Therapeutics General Information

Description

Poseida Therapeutics Inc is a clinical-stage biopharmaceutical company focused on leveraging non-viral gene engineering technologies to create life-saving therapeutics for patients with high unmet medical need. It has built a pipeline of autologous and allogeneic chimeric antigen receptor T cell, or CAR-T, product candidates, initially focused on the treatment of hematological malignancies and solid tumors.

Contact Information

Website
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Stock Exchange
NAS
Primary Office
  • 9390 Towne Center Drive
  • Suite 200
  • San Diego, CA 92121
  • United States
+1 (858) 000-0000

Poseida Therapeutics Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Poseida Therapeutics Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$9.25 $9.83 $7.63 - $17.62 $572M 61.8M 192K -$4.26

Poseida Therapeutics Financials Summary

In Thousands,
USD
TTM 30-Sep-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 761,877
Revenue 0 0 0 2,985
EBITDA (111,734) (81,781) (41,061) (18,955)
Net Income (117,240) (86,527) (44,404) (19,662)
Total Assets 405,171 146,996 45,120 25,454
Total Debt 58,873 29,140 19,086 9,708
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Poseida Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Poseida Therapeutics‘s full profile, request access.

Request a free trial

Poseida Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Poseida Therapeutics‘s full profile, request access.

Request a free trial

Poseida Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Poseida Therapeutics Inc is a clinical-stage biopharmaceutical company focused on leveraging non-viral gene engineering
Drug Discovery
San Diego, CA
186 As of 2020
00000
0000 0000-00-00
00000000 00000

0000000

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore
0000000000000
London, United Kingdom
000 As of 0000
00000
00000000 00000

0000000

ute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Exc
0000000000000
New York, NY
00 As of 0000
0000
00000000 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Poseida Therapeutics Competitors (46)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Autolus Formerly VC-backed London, United Kingdom 000 00000 00000000 00000
0000000 000 Corporation New York, NY 00 0000 00000000 0000
00000000 000000000 Formerly VC-backed Newtown, PA 00 00000 00000000 00000
00000 Formerly VC-backed Paris, France 00 00000 000000000 00000
00000000 Venture Capital-Backed San Carlos, CA 00 00000 00000000000 00000
You’re viewing 5 of 46 competitors. Get the full list »

Poseida Therapeutics Executive Team (13)

Name Title Board Seat Contact Info
Eric Ostertag Ph.D Chief Executive Officer & Chairman
Kerry Ingalls Chief Operating Officer, Operations
Kristin Martin Chief Human Resources Officer
Mark Gergen JD Board Member & Executive
Johanna Mylet Senior Vice President
You’re viewing 5 of 13 executive team members. Get the full list »

Poseida Therapeutics Board Members (13)

Name Representing Role Since
Catherine Mackey Ph.D Self Board Member 000 0000
David Hirsch Ph.D Longitude Capital Board Member 000 0000
Eric Ostertag Ph.D Poseida Therapeutics Chief Executive Officer & Chairman 000 0000
John Schmid Self Board Member 000 0000
Marcea Lloyd JD Self Board Member 000 0000
You’re viewing 5 of 13 board members. Get the full list »

Poseida Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Poseida Therapeutics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Poseida Therapeutics‘s full profile, request access.

Request a free trial

Poseida Therapeutics Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 10-Oct-2016 000000000000000000 0000 Drug Discovery
To view Poseida Therapeutics’s complete acquisitions history, request access »